The final phase of the study required 150 patients. When nRollmed joined 3 months in, 96 more patients were needed. The main challenge in this phase was the warp speed needed. Over the 6 years working on the study, nRollmed had developed close relationships with the sponsor and sites, many of whom had worked on several of the phases and requested to work with nRollmed again.
The messaging to patients and pre-screening process were optimized over the years to bring in the highest quality leads. The online platform was refined, with added features based on feedback from the sites.
With each aspect of nRollmed’s service enhanced over the years, this last phase commenced smoothly, and patients were randomized in record time. nRollmed provided 55 randomized patients in 2 months, more than doubling the monthly enrollment rate from 25 to 62, and saving 2 months of recruitment time. Screen fail rate improved by 20%.
nRollmed tripled the study’s monthly recruitment rate